Ascendis Pharma A/S — Company profile
Healthcare · Biotechnology · Denmark
Last price 251.27 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 16.50B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.
Details
| Name | Ascendis Pharma A/S |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 1189 |
| Founded | 2006 |
| Ipo Date | 2015-01-28 |
| Ceo | Jan Mikkelsen |
| Country | Denmark |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| Isin | DK0060615755 |
| Cusip | K08588103 |
| Cik | 0001612042 |
| Sic | 2834 |
Key executives
| Name | Title |
|---|---|
| Jan Moller Mikkelsen | President, Chief Executive Officer, Member of Executive Board and Executive Director |
| Scott T. Smith | Chief Financial Officer, Executive Vice President and Member of Executive Board |
| Pedersen Anni Lotte Kirstine Sonderbjerg | Executive Vice President, Chief Administrative Officer and Member of the Executive Board |
| Michael Wolff Jensen L.L.M. | Executive Vice President, Chief Legal Officer and Member of the Executive Board |
| Mads Bodenhoff | Senior Vice President, Head of Finance and Principal Accounting Officer |
| Chad Fugure | Vice President of Investor Relations |
| Flemming Steen Jensen | Executive Vice President of Product Supply and Quality |
| Dr. Kennett Sprogoe Ph.D. | Executive Vice President and Head of Research and Product Development |
| Joseph Kelly | Head of U.S. Commercial of Endocrinology |
Contact
| Address | Tuborg Boulevard 12, Hellerup, 2900, Denmark |
| Phone | 45 70 22 22 44 |
| Website | https://ascendispharma.com |